SOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational Zenflow Spring ® System offers ...
SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc. recently presented data from its BREEZEā„¢ pivotal clinical trial demonstrating the efficacy and safety of the Zenflow Spring® ...
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or ...
The Zenflow Spring implant provided immediate efficacy with durability and favorable safety over 12 months. The prostatic spring implant Zenflow® is effective for treating lower urinary tract symptoms ...
The U.S. FDA recently cleared two new medical devices to treat benign prostatic hyperplasia, offering men with enlarged prostates additional treatment options which are minimally invasive. The ...
SOUTH SAN FRANCISCO, Calif., April 26, 2025 (GLOBE NEWSWIRE) -- Zenflow, Inc. announced today the results of long-term data demonstrating that the investigational Zenflow Spring® System offers ...
SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc. recently presented data from its BREEZETM pivotal clinical trial demonstrating the efficacy and safety of the Zenflow ...
Round to Support PMA Submission of Minimally Invasive Treatment for Enlarged Prostate Symptoms SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc., a medical device company ...